United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 168,575 | 134,721 | 128,880 | 97,955 | 97,215 |
| Cost of Goods | 20,155 | 15,261 | 14,886 | 9,036 | 12,755 |
| Gross Profit | 148,420 | 119,460 | 113,994 | 88,919 | 84,460 |
| Operating Expenses | 86,085 | 58,502 | 82,634 | 91,381 | 73,478 |
| Operating Income | 62,490 | 61,219 | 32,246 | -2,426 | 11,737 |
| Interest Expense | 4,809 | 4,759 | 4,687 | 3,659 | 3,331 |
| Other Income | 662 | 851 | 1,122 | 1,209 | 640 |
| Pre-tax Income | 58,343 | 57,311 | 28,681 | -4,876 | 9,046 |
| Income Tax | 18,217 | 19,345 | 9,752 | -1,404 | -2,891 |
| Net Income Continuous | 40,126 | 37,966 | 18,929 | -3,472 | 11,937 |
| Net Income Discontinuous | -390 | -259 | N/A | N/A | N/A |
| Net Income | $39,736 | $37,707 | $18,929 | $-3,328 | $11,937 |
| EPS Basic Total Ops | 0.70 | 0.67 | 0.35 | -0.06 | 0.22 |
| EPS Basic Continuous Ops | 0.71 | 0.68 | 0.35 | -0.07 | 0.22 |
| EPS Basic Discontinuous Ops | -0.01 | 0.00 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.66 | 0.62 | 0.32 | -0.06 | 0.21 |
| EPS Diluted Continuous Ops | 0.67 | 0.63 | 0.32 | -0.07 | 0.21 |
| EPS Diluted Discontinuous Ops | -0.01 | -0.01 | N/A | N/A | N/A |
| EBITDA(a) | $72,354 | $70,472 | $41,295 | $6,743 | $18,657 |